BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14985168)

  • 1. DC-based immunotherapy of B-cell malignancies.
    Reichardt VL; Brossart P
    Cytotherapy; 2004; 6(1):62-7. PubMed ID: 14985168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of hematological malignancies using dendritic cells.
    Van de Velde AL; Berneman ZN; Van Tendeloo VF
    Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine strategies to treat lymphoproliferative disorders.
    Radford KJ; Vari F; Hart DN
    Pathology; 2005 Dec; 37(6):534-50. PubMed ID: 16373232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Le Dieu R; Gribben J
    Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in vaccination therapies of human malignant disease.
    Reichardt VL; Brossart P; Kanz L
    Blood Rev; 2004 Dec; 18(4):235-43. PubMed ID: 15501552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC in multiple myeloma immunotherapy.
    Turtle CJ; Brown RD; Joshua DE; Hart DN
    Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic strategies for the treatment of plasma cell malignancies.
    Treon SP; Raje N; Anderson KC
    Semin Oncol; 2000 Oct; 27(5):598-613. PubMed ID: 11049026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell vaccines for leukemia patients.
    Schmitt A; Hus I; Schmitt M
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):275-83. PubMed ID: 17338648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematology 2010].
    Dreyling M; Subklewe M; Braess J; Spiekermann K
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
    [No Abstract]   [Full Text] [Related]  

  • 14. Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders.
    Milosević DB
    J Exp Clin Cancer Res; 2004 Mar; 23(1):9-13. PubMed ID: 15149145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
    Kokhaei P; Adamson L; Palma M; Osterborg A; Pisa P; Choudhury A; Mellstedt H
    Cytotherapy; 2006; 8(4):318-26. PubMed ID: 16923607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based immunotherapy.
    Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
    Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.
    Takedatsu H; Yoshimoto K; Okamura T; Yakushij K; Imamura R; Hashiguchi M; Seki R; Obata Y; Harada M; Yamada A; Yamana H; Sata M; Itoh K
    Int J Oncol; 2005 Jun; 26(6):1605-12. PubMed ID: 15870876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.
    Bellone S; Pecorelli S; Cannon MJ; Santin AD
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1473-86. PubMed ID: 17944571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based immunotherapy for the treatment of hematological malignancies.
    Büchler T; Michalek J; Kovarova L; Musilova R; Hajek R
    Hematology; 2003 Apr; 8(2):97-104. PubMed ID: 12745659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.